Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP

Oncotarget. 2018 Aug 28;9(67):32882. doi: 10.18632/oncotarget.26080.

Hyunchul Jung^{1

2}, Hae Yong Yoo³, Seung Ho Lee³, Sohyun Shin⁴, Sang Cheol Kim², Sejoon Lee², Je-Gun Joung², Jae-Yong Nam^{3

2}, Daeun Ryu^{3

2}, Jae Won Yun^{2

5}, Jung Kyoon Choi¹, Ambarnil Ghosh⁵, Kyeong Kyu Kim⁵, Seok Jin Kim⁶, Won Seog Kim⁶, Woong-Yang Park¹, Young Hyeh Ko⁴

¹ Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
² Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
³ Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
⁴ Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
⁵ Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
⁶ Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.14928.].